ALS (motor neurone disease) trials in Netherlands

In Netherlands 15 Also abroad 226

15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Where
Utrecht
Age
18 years and over
People
36 worldwide
Run by
Vector Y Therapeutics
See details and how to joinNCT07287397 · EU 2025-522697-37-00
Phase 1Taking people
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Where
Utrecht
Age
18 years to 75 years
People
36 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07100119 · EU 2025-521295-60-00
Phase 3Taking people
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Where
Utrecht
Age
18 years to 80 years
People
500 worldwide
Run by
Prilenia
See details and how to joinNCT07322003
Phase 1/2Taking people
FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS
Where
Utrecht
Age
18 years to 75 years
People
30 worldwide
Run by
Trace Neuroscience, Inc.
See details and how to joinNCT07674667
Phase 1/2Taking people
A Randomized Phase 1 / 2 Trial Aiming to Restore UNC13A Function in People living with ALS: FUNCtion ALS
Where
Utrecht
Age
18 years and over
People
20 worldwide
Run by
Trace Neuroscience Inc.
See details and how to join2025-523111-11-00 · EU 2025-523111-11-00
Phase 1Taking people
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Where
Utrecht
Age
18 years to 80 years
People
32 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07571174
Phase 1Taking people
A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Where
Utrecht
Age
18 years to 80 years
People
32 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07571200 · EU 2026-525574-19-00
Phase 1/2Taking people
A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.
Where
Utrecht
Age
18 years to 80 years
People
80 worldwide
Run by
Nura Bio
See details and how to joinNCT07369076
Phase 2Taking people
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Where
Utrecht
Age
18 years and over
People
240 worldwide
Run by
Zydus Therapeutics Inc.
See details and how to joinNCT07023835 · EU 2025-522580-15-00
Early phase 1Taking people
[18F]ACI-19626 PET in TDP-43 Proteinopathies
Where
Amsterdam
Age
40 years to 70 years
People
45
Run by
AC Immune SA
See details and how to joinNCT06891716 · EU 2024-513097-21-00
Phase 1/2Taking people
A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis
Where
Utrecht
Age
18 years to 75 years
People
56 worldwide
Run by
Leal Therapeutics, Inc
See details and how to joinNCT07660614 · EU 2025-522039-33-00
Phase 1Taking people
Research into the safety of a new agent (NRG5051) in healthy adults and patients with Parkinson's disease or ALS
Where
Leiden
Age
18 years and over
People
118
Run by
Nrg Therapeutics Limited
See details and how to join2025-523872-22-00 · EU 2025-523872-22-00
Phase 3Taking people
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
Where
Utrecht
Age
18 years and over
People
420 worldwide
Run by
Ferrer Internacional S.A.
See details and how to join2025-524002-16-00 · EU 2025-524002-16-00
Phase 2Taking people
Psilocybin Therapy for Psychological Distress in Palliative Patients
Where
Groningen
Age
18 years and over
People
108 worldwide
Run by
University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01
No phaseTaking people
Investigation on the Cortical Communication System
Where
Utrecht
Age
18 years to 70 years
People
2
Run by
UMC Utrecht
See details and how to joinNCT06207591